Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Walker

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Acta Oncologica (Stockholm, Sweden)|November 25, 2017
Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case reportAbdul Rafeh Naqash, Li V Yang, Edward J Sanderlin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2020
Cell surface GRP78: An emerging imaging marker and therapeutic target for cancerMasoud Farshbaf, Ahmad Yari Khosroushahi, Solmaz Mojarad-Jabali, et al.
Clinical Breast Cancer|March 19, 2016
Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBCTithi Biswas, Jimmy T Efird, Shreya Prasad, et al.
Springerplus|July 8, 2016
Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white womenShreya Prasad, Jimmy T Efird, Sarah E James, et al.
European Journal of Immunology|May 2, 2015
Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cellsRomain Vuillefroy de Silly, Laura Ducimetière, Céline Yacoub Maroun, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
Continuous infusion interleukin-2 and famotidine in metastatic kidney cancerWalter D Y Quan, Mikhail Vinogradov, Francine M Quan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cellsFrédérick Masson, Thomas Calzascia, Wilma Di Berardino-Besson, et al.
Frontiers in Oncology|January 26, 2023
Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapyChristine Son, Melissa Y Y Moey, Paul R Walker, et al.
International Journal of Pharmaceutics|April 29, 2021
An update on actively targeted liposomes in advanced drug delivery to gliomaSolmaz Mojarad-Jabali, Masoud Farshbaf, Paul R Walker, et al.
Plos One|May 30, 2013
Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumoursSabine Hoepner, Jacelyn M S Loh, Cristina Riccadonna, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Acta Oncologica (Stockholm, Sweden)|November 25, 2017
Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case reportAbdul Rafeh Naqash, Li V Yang, Edward J Sanderlin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2020
Cell surface GRP78: An emerging imaging marker and therapeutic target for cancerMasoud Farshbaf, Ahmad Yari Khosroushahi, Solmaz Mojarad-Jabali, et al.
Clinical Breast Cancer|March 19, 2016
Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBCTithi Biswas, Jimmy T Efird, Shreya Prasad, et al.
Springerplus|July 8, 2016
Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white womenShreya Prasad, Jimmy T Efird, Sarah E James, et al.
European Journal of Immunology|May 2, 2015
Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cellsRomain Vuillefroy de Silly, Laura Ducimetière, Céline Yacoub Maroun, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
Continuous infusion interleukin-2 and famotidine in metastatic kidney cancerWalter D Y Quan, Mikhail Vinogradov, Francine M Quan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cellsFrédérick Masson, Thomas Calzascia, Wilma Di Berardino-Besson, et al.
Frontiers in Oncology|January 26, 2023
Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapyChristine Son, Melissa Y Y Moey, Paul R Walker, et al.
International Journal of Pharmaceutics|April 29, 2021
An update on actively targeted liposomes in advanced drug delivery to gliomaSolmaz Mojarad-Jabali, Masoud Farshbaf, Paul R Walker, et al.
Plos One|May 30, 2013
Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumoursSabine Hoepner, Jacelyn M S Loh, Cristina Riccadonna, et al.
Pageof 10